Episomal vectors rapidly and stably produce high-titer recombinant retrovirus

Human Gene Therapy

Volumn 7, Issue 12, 1996, Pages 1405-1413

  Kinsella, Todd M ^a   Nolan, Garry P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PUROMYCIN;

ARTICLE; EPISOME; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NONHUMAN; RETROVIRUS; VIRUS CELL INTERACTION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TITRATION;

HUMAN HERPESVIRUS 4; UNIDENTIFIED RETROVIRUS;

EID: 0029833422     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.12-1405     Document Type: Article

References (36)

1. ADAMS, A. (1987). Replication of latent Epstein-Barr virus genomes in Raji cells. J. Virol. 61, 1743-1746.
2. BENOIST, C., and CHAMBON, P. (1981). In vivo sequence requirements of the SV40 early promoter region. Nature 290, 304-310.
3. BIAMONTI, G., DELLA VALLE, G., TALARICO, D., COBIANCHI, F., RIVA, S., and FALASCHI, A. (1985). Fate of exogenous recombinant plasmids introduced into mouse and human cells. Nucleic Acids Res. 13, 5545-5561.
4. DAI, Y., ROMAN, M., NAVIAUX, R.K., and VERMA, I.M. (1992). Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89, 10892-10895.
5. DE LA LUNA, S., SORIA, I., PULIDO, D., ORTIN, J., and JIMENEZ, A. (1988). Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker. Gene 62, 121-126.
6. DUBRIDGE, R.B., TANG, P., HSIA, H.-C., LEONG, P.-M., MILLER, J.H., and CALOS, M.P. (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle vector. Mol. Cell. Biol. 7, 379-387.
7. FINER, M.H., DULL, T.J., QIN, L., FARSON, D., and ROBERTS, M.R. (1994). kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 83, 43-50.
8. FROMM, M., and BERG, P. (1982). Deletion mapping of DNA regions required for SV40 early region promoter function in vivo. J. Mol. Appl. Genet. 1, 457-481.
9. HAASE, S.B., and CALOS, M.P. (1991). Replication control of autonomously replicating human sequences. Nucleic Acids Res. 19, 5053-5058.
10. HAASE, S.B., HEINZEL, S., KRYSAN, P., and CALOS, M. (1989). Improved EBV shuttle vectors. Mutat. Res. 220, 125-132.
11. HEINZEL, S.S., KRYSAN, P.J., CALOS, M.P., and DUBRIDGE, R.B. (1988). Use of Simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells. J. Virol. 62, 3738-3746.
12. HIRT, B. (1967). Selective extraction of polyma DNA from infected mouse cultures. J. Mol. Biol. 26, 365-369.
13. KASAHARA, N., DOZY, A.M., and KAN, Y.W. (1994). Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373-1375.
14. KITAMURA, T., ONISHI, M., KINOSHITA, S., MIYAJIMA, A., and NOLAN, G.P. (1995). Efficient screening of retroviral cDNA expression libraries. Proc. Natl. Acad. Sci. USA 92, 9146-9150.
15. KRASNOW, M.A., CUMBERLEDGE, G.M., HERZENBERG, L.A., and NOLAN, G.P. (1991). Whole animal cell sorting of Drosophila embryos. Science 251, 81-85.
16. KRAUSS, J.C. (1992). Hematopoietic stem cell gene replacement therapy. Biochim. Biophys. Acta 1114, 193-207.
17. KRYSAN, P.J., and CALOS, M.P. (1993). Epstein-Barr virus-based vectors that replicate in rodent cells. Gene 136, 137-143.
18. KRYSAN, P.J., HAASE, S.B., and CALOS, M.P. (1989). Isolation of human sequences that replicate autonomously in human cells. Mol. Cell. Biol. 9, 1026-1033.
19. LANDAU, N.R., and LITTMAN, D.R. (1992). Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66, 5110-5113.
20. LUPTON, S., and LEVINE, A.J. (1985). Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol. Cell. Biol. 5, 2533-2542.
21. MANN, R., MULLIGAN, R.C., and BALTIMORE, D. (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33, 153-159.
22. MILLER, A.D. (1990). Retrovirus packaging cells. Hum. Gene Ther. 1, 5-14.
23. MORGENSTERN, J.P., and LAND, H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging line. Nucleic Acids Res. 18, 3587-3596.
24. MULLIGAN, R.C. (1993). The basic science of gene therapy. Science 260, 926-932.
25. NOLAN, G.P., FIERING, S., NICOLAS, J.-F., and HERZENBERG, L.A. (1988). Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-galactosidase activity after transduction of E. coli lacZ. Proc. Natl. Acad. Sci. USA 85, 2603-2607.
26. PEAR, W., NOLAN, G., SCOTT, M., and BALTIMORE, D. (1993). Production of high-liter helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.
27. PEAR, W.S., SCOTT, M.L., and NOLAN, G.P. (1995). Rapid production of high-liter, helper-free retroviruses using transient transfection. Meth. Gene Ther. (in press).
28. PRICE, J., TURNER, D., and CEPKO, C. (1987). Lineage analysis in the invertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84, 156-160.
29. RAWLINS, D.R., MILMAN, G., HAYWARD, S.D., and HAYWARD, G.S. (1985). Sequence-specific DNA binding of the Epstein-Barr nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42, 859-868.
30. REISMAN, D., and SUGDEN, B. (1986). trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6, 3838-3846.
31. REISMAN, D., YATES, J., and SUGDEN, B. (1985). A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5, 1822-1832.
32. WATANABE, S., and TEMIN, H.M. (1983). Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol. Cell. Biol. 3, 2241-2249.
33. YATES, J., WARREN, N., and SUGDEN, B. (1988). Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1. Cancer Cells 6, 197-205.
34. YATES, J., WARREN, N., REISMAN, D., and SUGDEN, B. (1984). A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81, 3806-3810.
35. YATES, J.L., WARREN, N., and SUGDEN, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-814.
36. YEH, W.C., CAO, Z., CLASSON, M., and McKNIGHT, S.L. (1995). Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes & Dev. 9, 168-181.